# FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

Study · id `cardio:ct-nct01071122` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01071122](<https://clinicaltrials.gov/study/NCT01071122>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01071122

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.

## Technical summary

Registry record NCT01071122. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 365 participants (enrolled count; ClinicalTrials.gov record NCT01071122, source copy `cardio:ctgov-nct01071122-2014-01-27`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01071122, source copy `cardio:ctgov-nct01071122-2014-01-27`, retrieved 2026-10-26)
- Primary completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01071122, source copy `cardio:ctgov-nct01071122-2014-01-27`, retrieved 2026-10-26)
- Completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01071122, source copy `cardio:ctgov-nct01071122-2014-01-27`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01071122, source copy `cardio:ctgov-nct01071122-2014-01-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01071122-2014-01-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)
- Condition: Hypertension
- Intervention (Drug): Nifedipine (Adalat, BAYA1040) and Valsartan
- Intervention (Drug): Nifedipine (Adalat, BAYA1040)
- Intervention (Drug): Valsartan
- Lead sponsor: Bayer
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Valsartan (`cardio:valsartan`)
- Registry lists this organization as the lead sponsor: Bayer (`cardio:bayer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study (`cardio:pubmed-26996246`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1f621a44b5c55d254562bd7f2afdccba94037adecc2376336a5e06f2927b1ec8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
